Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baofa Cancer Hospital is a specialized oncology healthcare provider and research institution founded by Dr. Yu Baofa. The hospital is renowned for its proprietary Ultra-fractionated Intra-tumoral Chemotherapy (UFIC) technology, which involves the direct injection of chemotherapy drugs combined with haptens into solid tumors. This approach aims to maximize local drug concentration while minimizing systemic toxicity and inducing an autologous vaccine-like immune response. With multiple locations in China, including Jinan and Beijing, the institution focuses on treating advanced-stage cancers that are often resistant to conventional therapies. The hospital integrates clinical practice with ongoing research into personalized cancer immunotherapy and minimally invasive treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baofa Cancer Hospital.